AI assistant
AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2020
Jun 1, 2020
31580_dirs_2020-06-01_3e7afcbb-9fc4-4f8d-8469-afc9df872ced.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AGIOS PHARMACEUTICALS, INC. (AGIO)
CIK: 0001439222
Period of Report: 2020-05-28
Reporting Person: Scadden David (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-05-29 | Common stock | M | 1878 | — | Acquired | 3849 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-05-28 | Stock options (right to buy) | $53.35 | A | 8096 | Acquired | 2030-05-28 | Common stock (8096.0) | Direct |
| 2020-05-28 | Restricted stock units | $ | A | 1686 | Acquired | Common stock (1686.0) | Direct | |
| 2020-05-29 | Restricted stock units | $ | M | 1878 | Disposed | Common stock (1878.0) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F2: This option was granted on May 28, 2020. This option vests as to 100% of the underlying shares on May 28, 2021.
F3: The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested.
F4: The restricted stock units were granted on May 29, 2019. The shares underlying the stock units will vest in full on May 29, 2020. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested.